Cerebral Mechanism Involved in Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics (IIT).
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2015
At a glance
- Drugs Olanzapine (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 13 Mar 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 13 Mar 2013 Actual initiation date changed from Sep 2005 to Sep 2006 as reported by ClinicalTrials.gov.